These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10932146)

  • 21. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology.
    Kar S; Quirion R
    Prog Brain Res; 2004; 145():261-74. PubMed ID: 14650921
    [No Abstract]   [Full Text] [Related]  

  • 24. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
    Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
    Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
    Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
    ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.
    Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU
    Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
    Ono M; Haratake M; Mori H; Nakayama M
    Bioorg Med Chem; 2007 Nov; 15(21):6802-9. PubMed ID: 17826102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's amyloid-beta rescues yeast from hydroxide toxicity.
    Dubey AK; Bharadwaj PR; Varghese JN; Macreadie IG
    J Alzheimers Dis; 2009; 18(1):31-3. PubMed ID: 19542608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
    Ricciarelli R; D'Abramo C; Zingg JM; Giliberto L; Markesbery W; Azzi A; Marinari UM; Pronzato MA; Tabaton M
    Free Radic Biol Med; 2004 Apr; 36(8):1018-24. PubMed ID: 15059642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alzheimer's disease and amyloid protein--in (transgenic) mice and man].
    Nussbaum M; Korczyn AD
    Harefuah; 1992 Nov; 123(9):362-4. PubMed ID: 1473774
    [No Abstract]   [Full Text] [Related]  

  • 39. Alzheimer's disease. Progress in molecular pathology.
    Anderton BH
    Nature; 1987 Feb 19-25; 325(6106):658-9. PubMed ID: 3547138
    [No Abstract]   [Full Text] [Related]  

  • 40. Amyloid, aluminum and the aetiology of Alzheimer's disease.
    Exley C
    Med J Aust; 1996 Feb; 164(4):252-3. PubMed ID: 8604204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.